CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-15 | Love Colin Chief Operating Officer | Sale | −12,396 | $43.07 | $534K | 954,381 |
| 2021-01-15 | Omega Fund IV, L.P. Director | Sale | −1,916 | $45.19 | $87K | 5,325,391 |
| 2021-01-14 | Esposito Pamela Chief Business Officer | Option exercise | +20,000 | $1.01 | $20K | 195,994 |
| 2021-01-14 | Esposito Pamela Chief Business Officer | Sale | −20,000 | $45.02 | $900K | 175,994 |
| 2021-01-14 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −20,000 | 108,203 | ||
| 2021-01-14 | Astley-Sparke Philip Chief Executive Officer | Sale | −17,452 | $44.78 | $782K | 1,287,845 |
| 2021-01-14 | Astley-Sparke Philip Chief Executive Officer | Sale | −7,448 | $43.61 | $325K | 1,280,397 |
| 2021-01-14 | Astley-Sparke Philip Chief Executive Officer | Sale | −100 | $43.06 | $4K | 1,280,297 |
| 2021-01-14 | Esposito Pamela Chief Business Officer | Option exercise | +20,000 | $1.01 | $20K | 195,994 |
| 2021-01-14 | Esposito Pamela Chief Business Officer | Sale | −20,000 | $45.02 | $900K | 175,994 |
| 2021-01-14 | Esposito Pamela Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −20,000 | 108,203 | ||
| 2021-01-14 | Omega Fund IV, L.P. Director | Sale | −17,664 | $45.09 | $796K | 5,327,307 |
| 2021-01-14 | Franchi Jean M. Chief Financial Officer | Option exercise | +14,900 | $14.08 | $210K | 14,900 |
| 2021-01-14 | Franchi Jean M. Chief Financial Officer | Sale | −14,300 | $44.55 | $637K | 600 |
| 2021-01-14 | Franchi Jean M. Chief Financial Officer | Sale | −600 | $44.00 | $26K | 0 |
| 2021-01-14 | Franchi Jean M. Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −14,900 | 140,000 | ||
| 2021-01-13 | Franchi Jean M. Chief Financial Officer | Option exercise | +100 | $14.08 | $1K | 100 |
| 2021-01-13 | Franchi Jean M. Chief Financial Officer | Sale | −100 | $44.19 | $4K | 0 |
| 2021-01-13 | Franchi Jean M. Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −100 | 154,900 | ||
| 2020-12-23 | Esposito Pamela Chief Business Officer | Option exercise | +50,704 | $1.75 | $89K | 175,994 |
Page 17 of 19 · 365 trades